Plx Pharma Stock Future Price Prediction

PLXP
 Stock
  

USD 2.36  0.05  2.16%   

Plx Pharma stock price prediction is an act of determining the future value of Plx Pharma shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Plx Pharma's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Plx Pharma and does not consider all of the tangible or intangible factors available from Plx Pharma's fundamental data. We analyze noise-free headlines and recent hype associated with Plx Pharma, which may create opportunities for some arbitrage if properly timed.
Please check Plx Pharma Basic Forecasting Models to cross-verify your projections.
  
Refresh
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Plx Pharma based on different types of headlines from major news networks to social media. The Plx Pharma stock price prediction module provides an analysis of price elasticity to changes in media outlook on Plx Pharma over a specific investment horizon.
EPS Estimate Current Year
-1.77
EPS Estimate Next Year
-0.94
Wall Street Target Price
14.0
EPS Estimate Current Quarter
-0.72
Quarterly Revenue Growth YOY
-1.0
Using Plx Pharma hype-based prediction, you can estimate the value of Plx Pharma from the perspective of Plx Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Plx Pharma using Plx Pharma's options and short interest. It helps to benchmark the overall future attitude of investors towards Plx Pharma using crowd psychology based on the activity and movement of Plx Pharma's stock price.

Plx Pharma Implied Volatility

    
  146.98  
Plx Pharma's implied volatility exposes the market's sentiment of Plx Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Plx Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Plx Pharma stock will not fluctuate a lot when Plx Pharma's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Plx Pharma. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Plx Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Plx Pharma because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Plx Pharma after-hype prediction price

    
  $ 2.07  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Plx Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Plx Pharma in the context of predictive analytics.
Intrinsic
Valuation
LowReal ValueHigh
0.173.4810.01
Details
Naive
Forecast
LowNext ValueHigh
0.052.609.12
Details
2 Analysts
Consensus
LowTarget PriceHigh
6.007.008.00
Details
Earnings
Estimates (2)
LowProjected EPSHigh
-1.61-1.53-1.46
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Plx Pharma. Your research has to be compared to or analyzed against Plx Pharma's peers to derive any actionable benefits. When done correctly, Plx Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Plx Pharma.

Plx Pharma After-Hype Price Prediction Density Analysis

As far as predicting the price of Plx Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Plx Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many smart people who confused the symmetrical distributions of stock prices, such as prices of Plx Pharma, with the unreliable approximations that try to describe financial returns.
 Next price density 
      Expected price to next headline 

Plx Pharma Estimiated After-Hype Price Volatility

In the context of predicting Plx Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Plx Pharma's historical news coverage. Plx Pharma's after-hype downside and upside margins for the prediction period are 0.10 and 8.60, respectively. We have considered Plx Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value 2.36
2.07
After-hype Price
8.60
Upside
Plx Pharma is very risky asset. Analysis and calculation of next after-hype price of Plx Pharma is based on 3 months time horizon.

Plx Pharma Stock Price Prediction Analysis

Have you ever been surprised when a price of a company such as Plx Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Plx Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Plx Pharma, there might be something going there, and it might present an excellent short sale opportunity.
Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
  0.67  6.53   0.29    0.78  3 Events / Month1 Events / MonthIn about 3 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.362.0712.29 
1,519  

Plx Pharma Hype Timeline

Plx Pharma is at this time traded for 2.36. The entity has historical hype elasticity of -0.29 and average elasticity to hype of competition of -0.78. Plx Pharma is anticipated to decline in value after the next headline with price expected to drop to 2.07. The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -12.29% whereas the daily expected return is at this time at -0.67%. The volatility of related hype on Plx Pharma is about 558.12% with expected price after next announcement by competition of 1.58. About 16.0% of the company outstanding shares are owned by corporate insiders. The book value of Plx Pharma was at this time reported as 1.12. The company recorded a loss per share of 3.1. Plx Pharma had not issued any dividends in recent years. The entity had a split on the 20th of April 2017. Given the investment horizon of 90 days the next anticipatedpress releasewill be in about 3 days.
Please check Plx Pharma Basic Forecasting Models to cross-verify your projections.

Plx Pharma Related Hype Analysis

Having access to credible news sources related to Plx Pharma's direct competition is more important than ever and may enhance your ability to predict Plx Pharma's future price movements. Getting to know how Plx Pharma rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Plx Pharma may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
WMTWalmart(1.17) 7 per month 0.00 (0.0269)  2.43 (2.47)  13.98 

Plx Pharma Additional Predictive Modules

Most predictive techniques to examine Plx Pharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Plx Pharma using various technical indicators. When you analyze Plx Pharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Plx Pharma Predictive Indicators

The successful prediction of Plx Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Plx Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Plx Pharma based on analysis of Plx Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Plx Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Plx Pharma's related companies.

Story Coverage note for Plx Pharma

The number of cover stories for Plx Pharma depends on current market conditions and Plx Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Plx Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Plx Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Plx Pharma Short Properties

Plx Pharma's future price predictability will typically decrease when Plx Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Plx Pharma often depends not only on the future outlook of the potential Plx Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Plx Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
Shares Percent Shares Out10.89%
Short Percent Of Float11.11%
Float Shares20.06M
Shares Short Prior Month3.02M
Average Daily Volume Last 10 Day221.61k
Average Daily Volume In Three Month191.48k
Date Short Interest29th of April 2022
Please check Plx Pharma Basic Forecasting Models to cross-verify your projections. Note that the Plx Pharma information on this page should be used as a complementary analysis to other Plx Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Plx Pharma Stock analysis

When running Plx Pharma price analysis, check to measure Plx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plx Pharma is operating at the current time. Most of Plx Pharma's value examination focuses on studying past and present price action to predict the probability of Plx Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Plx Pharma's price. Additionally, you may evaluate how the addition of Plx Pharma to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Is Plx Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Plx Pharma. If investors know Plx Pharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Plx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
65 M
Quarterly Revenue Growth YOY
-1.0
Return On Assets
-0.46
Return On Equity
-0.82
The market value of Plx Pharma is measured differently than its book value, which is the value of Plx Pharma that is recorded on the company's balance sheet. Investors also form their own opinion of Plx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Plx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Plx Pharma's market value can be influenced by many factors that don't directly affect Plx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Plx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Plx Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Plx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.